Cargando…
Metformin: an old but still the best treatment for type 2 diabetes
The management of T2DM requires aggressive treatment to achieve glycemic and cardiovascular risk factor goals. In this setting, metformin, an old and widely accepted first line agent, stands out not only for its antihyperglycemic properties but also for its effects beyond glycemic control such as im...
Autores principales: | Rojas, Lilian Beatriz Aguayo, Gomes, Marilia Brito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607889/ https://www.ncbi.nlm.nih.gov/pubmed/23415113 http://dx.doi.org/10.1186/1758-5996-5-6 |
Ejemplares similares
-
Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
por: Levy, Juliana, et al.
Publicado: (2010) -
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007) -
Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
por: Haak, Thomas
Publicado: (2015) -
Correction: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
por: Levy, Juliana, et al.
Publicado: (2010) -
Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
por: Kinaan, Mustafa, et al.
Publicado: (2015)